Uterine Fibroids

Uterine Artery Embolization is one of the most well-studied minimally invasive treatments for uterine fibroids and adenomyosis, with excellent long-term outcomes.

Clinical studies have shown:

• 90–95% of women experience significant improvement in their symptoms. Heavy menstrual bleeding often improves with the first menstrual cycle after treatment. Fibroids gradually shrink over 6–12 months, relieving pelvic pressure, urinary frequency, constipation, bloating, and pelvic pain.
• 75–80% of women with adenomyosis experience significant improvement in their symptoms.
• Most women avoid hysterectomy and return to their normal activities within 5–10 days.
• UAE has a complication rate of less than 1%, which is lower than many traditional surgical procedures.

Our goal is to provide long-lasting symptom relief while preserving the uterus and minimizing recovery time.

No. Most patients receive conscious (twilight) sedation.

No. UAE is an outpatient procedure, and most patients go home the same day.

Most women return to work in 5–10 days.

Cramping, fatigue, low-grade fever, and mild nausea are expected and improve over several days.

Many women notice progressively lighter bleeding starting with their first menstrual cycle. Fibroids continue shrinking over 6–12 months.

Only a tiny wrist or groin puncture that heals with little or no visible scar.

Cramping is expected but is managed with medications during and after the procedure.

They lose their blood supply, shrink over 6–12 months, and become scar tissue.

Yes. UAE is effective for many women with adenomyosis as well as fibroids.

During UAE, tiny medical-grade particles are injected into the arteries that supply blood to the fibroids or adenomyosis. These particles become permanently lodged within the small blood vessels feeding the treated tissue, blocking its blood supply.

The particles remain safely in place and do not travel throughout the body. Over time, the fibroids shrink and become scar tissue because they no longer receive oxygen and nutrients. The surrounding healthy uterine tissue continues to receive blood flow through other normal blood vessels.

The embolic particles have been used safely in Interventional Radiology procedures for many years and are made from biocompatible materials designed to remain in the treated blood vessels without causing harm to the rest of the body.

A consultation, MRI review, and collaboration with your gynecologist determine candidacy.

Yes. A pelvic MRI, gynecologic evaluation, and consultation are completed before treatment.

Discuss future pregnancy plans with your gynecologist and our team so treatment can be individualized.

Yes. We work closely with your gynecologist before, during, and after treatment.

UAE is performed by specially trained Interventional Radiologists.

Yes. Most women continue to have menstrual periods after UAE. The goal is to reduce heavy bleeding and improve symptoms—not to stop normal menstrual cycles. Women nearing natural menopause may experience changes in their menstrual cycle.

The procedure generally takes 60–90 minutes, with most patients going home within a few hours.

Yes. Uterine Artery Embolization (UAE) is a well-established, FDA-approved procedure and is covered by most major commercial insurance plans, as well as Medicare, for patients who meet medical necessity criteria.

Buffalo Vascular Care proudly welcomes patients from Canada seeking advanced, minimally invasive treatment for uterine fibroids and adenomyosis.

Located just minutes from the Canadian border, our accredited outpatient center provides convenient access to Uterine Artery Embolization (UAE) for women looking for a non-surgical alternative to hysterectomy or myomectomy. For more information you can reach us at manager@buffalovascularcare.com.